Investors in Medical Device

The MVC manages a €10 million fund by investing equity in start-up companies operating within the digital economy and innovative economic sectors that contribute significant value to the Maltese economy. Eligible companies may include those involved in video game development, fintech, e-sports, life sciences, pharma, green energy, the filming industry, agritech, AI, communications, electronics, financial services, medical devices, software, bluewater industries, and digital technology. Start-up companies operating in innovative economic sectors will have access to the newly established fund, with each start-up being eligible for up to €500,000 in the form of equity investment. The investment by the fund will be pari-passu with that of private venture capital investors. The Malta Government Venture Capital Limited will be the sole entity responsible for administering this scheme.

Vivalto Partners is an independent European management company approved by the Autorité des Marchés Financiers, specializing in investment in the healthcare sector. We invest in profitable SMEs and mid-cap companies and support their managers in their development projects, in capital and through strategic and operational support. Founded in 2021 by Daniel Caille, a pioneering figure in private healthcare in France, Vivalto Partners brings together healthcare experts and investment professionals in an approach to supporting players who contribute to the quality of care to meet the major challenges of transforming the sector in Europe.

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world's most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies.

Abingworth is a distinguished international investment firm specializing in the life sciences and healthcare sectors. Founded in 1973, we have a long-standing reputation for supporting innovative companies at various stages of development, from early-stage startups to late-stage growth enterprises. Our investment portfolio spans biotechnology, pharmaceuticals, medical devices, and healthcare services, reflecting our commitment to advancing cutting-edge technologies and treatments. With our team of seasoned professionals bringing deep industry knowledge and extensive experience, we provide strategic guidance and operational support to our portfolio companies. Our global presence, with offices in London, Menlo Park, and Boston, allows us to identify and invest in promising opportunities worldwide. Dedicated to fostering innovation and improving patient outcomes, we have successfully supported numerous companies in achieving significant milestones, demonstrating our ability to add value and drive growth.

Stonehaven Incubate looks at disruptive technologies in human health and identifies the unique opportunities for animals. So we shake hands with the innovators and build strategies for new, stand-alone animal health companies. We find experienced management teams. We source the capital required. In fact, we leave no stone unturned in our quest to bring human innovations to animal health.

BrainDTech is focused on the early diagnosis and monitoring of neurological and neurodegenerative disorders, leveraging advanced technology and innovative research. By providing accurate and timely insights, BrainDTech aims to improve patient outcomes and quality of life. Their commitment to excellence drives the development of cutting-edge solutions in the field of neurology.

Vision Health Pioneers Incubator' is a healthcare Startup program based in Berlin connecting and educating healthcare innovators in Europe. We support tech entrepreneurs with workshops, access to technology and business opportunities. We are funded by the Berlin Senate and the European Social Fund (ESF) and managed by Startup Colors UG.

VITA Accelerator is the Digital Health Accelerator of CDP National Accelerators Network, born from the initiative of CDP Venture Capital SGR together with Healthware Group and Accelerace.We are glad to announce the launch of a novel Program, aimed to support startups based in Italy or interested in expanding to Italy.

XN-Ventures is a Finnish incubator and investment company that aims to accelerate companies' growth and success in international markets.We offer strategic guidance, investment, and resources to help businesses expand globally. At XN-Ventures, our mission is to drive innovation and support companies in achieving global impact.

LSI is a pre-seed and seed stage venture capital in Poland. We invest in early-stage start ups in life science domain. LSI is a Venture Capital Fund focused on polish life science startups in pre-seed and seed stages. We currently have 11 start-ups in our portfolio. We have startups in the field of medtech, digital health, biotech, environment protection.

MD Start is an incubator and fund dedicated to medical technologies. MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding.

Furthr VC is a relationship-driven early-stage venture capital firm investing in ambitious founders building the future. They focus on Seed to Series A investments in globally oriented Irish software and medtech companies, offering hands-on support and strategic guidance to accelerate growth. With over 50 early-stage companies backed across 100+ investment rounds, Furthr VC reserves significant capital for follow-on investments to support founders throughout their journey.